The regulators dramatically revised their proposals in response to strong pushback from the financial industry. Among other things, the updated proposals would increase the common equity…
Pfizer’s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the…
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can’t control the latter, but they can focus on a company’s…
If there’s one sector that’s crucial to keep an eye on, that’s banking. Today, we’ll zero in on the Bank of America’s (BofA) Q2 2024 earnings…
Climate anxiety is very real, but these good news stories from 2024 prove there is hope for our planet. ADVERTISEMENTEco-anxiety, climate doom, environmental existential dread -…
Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical…
The coronavirus pandemic has led to some reduction in revenues but so far these have been offset by cost-cutting measures. (), which in January announced it…
PLC’s () Craig Moulton talks Proactive’s Andrew Scott through the results of its recent stage 2 sampling programme at the Wudinna project in Australia which he…
Catenae Innovation PLC’s (LON:CTEA) Guy Meyer caught up with Proactive London’s Andrew Scott after announcing its partner Newcastle Premier Health has successfully completed a proof-of-concept pilot…